Cancer trends: rising worldwide, declining mortality in Germany

Across the world, cancer incidence continues to rise sharply. Over the past few decades, the number of new cancer cases has more than doubled. According to the Global Burden of Disease study, 2023 saw 18.5 million new diagnoses and 10.4 million deaths linked to cancer. By 2050, experts project up to 30.5 million new cases annually, largely driven by population growth and global aging.

Yet there is encouraging news. In high-income countries, age-adjusted cancer rates have begun to stabilize or even decline. Germany offers a striking example: over the past thirty years, cancer incidence has increased by only 3 percent, while mortality has dropped by nearly 25 percent. This remarkable progress reflects decades of investment in prevention, early detection, and advanced treatment solutions.

In contrast, many low – and middle – income nations face worsening trends, with both incidence and mortality continuing to climb. The sharpest increase has been observed in Lebanon, where cancer rates have risen by more than 50 percent.

Breast cancer remains the most common malignancy worldwide, while lung cancer continues to be the leading cause of cancer-related deaths. Experts note that up to 42 percent of global cancer deaths could be prevented through reduction of key risk factors: smoking, poor diet, and high blood sugar levels.

Despite the growing global burden, researchers emphasize that cancer control still lacks sufficient government prioritization in many regions. Progress depends on stronger public health strategies focused on prevention, early screening access, and equitable treatment availability.

For clients seeking the most effective preventive and diagnostic programs, Germany’s medical system stands out for its proven efficiency, innovation, and exceptional long-term outcomes.

Deutsches Ärzteblatt, 25 septembre 2025. Source